Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYInternational journal of medical sciences

Interaction Between Age and the NOTCH3 p.R544C Variant in Determining Ischemic Stroke Risk: Insights from the Taiwan Biobank Study of 8,588 Patients.

  • Yi-Ching Liaw1,2,3
  • Oswald Ndi Nfor4
  • Che-Hong Chen5
  • Shu-Yi Hsu3
  • Yi-Chia Liaw6,7
  • Yung-Po Liaw3,4,8
8 affiliations
  1. 1Department of Nutrition, China Medical University, Taichung 40678, Taiwan.
  2. 2Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan.
  3. 3Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan.
  4. 4Department of Public Health, College of Public Health, China Medical University, 406040, Taichung, Taiwan.
  5. 5Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  6. 6Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  7. 7Division of Neurology, Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan.
  8. 8Department of Medical Research, China Medical University Hospital, China Medical University, Taichung City, Taiwan.
Read full textPDFDOICite

Abstract

Genetic susceptibility to ischemic stroke may vary across the life course, yet the extent to which aging modifies the effect of specific high-risk variants remains incompletely understood. The NOTCH3 rs201118034 (p.R544C) variant, a CADASIL-related mutation with relatively high prevalence in East Asian populations, has been associated with cerebrovascular disease. We investigated whether age modifies the association between the NOTCH3 p.R544C variant and ischemic stroke risk at the population level. We integrated data from the Taiwan Biobank (TWB, 2008-2020) with the National Health Insurance Research Database (NHIRD, 2000-2020). Among 112,500 participants, 8,588 ischemic stroke cases were identified. Participants were classified as wild-type (GG) or p.R544C carriers (AG+AA). Logistic regression models were used to estimate stroke risk after adjusting for demographic characteristics, vascular comorbidities, and lifestyle factors. Effect modification by age was evaluated using interaction terms and age-genotype-stratified analyses. Overall, p.R544C carriers exhibited a higher prevalence of ischemic stroke than noncarriers (10.37% vs. 7.61%). The p.R544C variant was associated with higher odds of ischemic stroke (adjusted odds ratio [OR], 1.54; 95% confidence interval [CI], 1.24-1.90). Age was a strong determinant of stroke risk, and a significant interaction between age and genotype was observed (p for interaction = 0.02), indicating that the effect of age on ischemic stroke risk varied by genotype. In the joint age-genotype model, the highest odds of ischemic stroke were observed among AG+AA carriers aged 51-60 years (OR 7.07, 95% CI 5.08-9.82) and 61-70 years (OR 11.40, 95% CI 8.02-16.19), relative to 30-40-year-old GG carriers. These findings indicate that the association between the NOTCH3 p.R544C variant and ischemic stroke risk is age-dependent. The progressively stronger genetic effect observed in later adulthood underscores the importance of incorporating age-specific genetic susceptibility into population-based stroke risk stratification and neurogenetic epidemiology.

Related

  1. Association between the Lactate-to-hematocrit Ratio and the Outcomes in Ischemic Stroke Patients: Insights from MIMIC-IV
    Yumiao Teng, Qing Wang
    Journal of Atherosclerosis and ThrombosisPeer-reviewedCC BY-NC-SAFull textEpidemiology & public healthJ-STAGE
  2. Genetic Variant Burden Rises with BMI: Insights from Rare and Low-Frequency Variants in Obesity
    S. E. John, A. Channanath, M. Z. Malik +3
    medRxivPreprintAll rights reservedFull textHuman geneticsmedRxiv
  3. Novel variant and enteroendocrine hormone deficiency in a patient with proline and glutamate‐rich protein with a coiled coil domain 1 (PERCC1) associated enteropathy: New diagnostic and therapeutic insights
    Teresa Di Chio, Daniela Gattini, Christina Belza +7
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Validation of individualized flow simulations for determining the pressure gradient in patients with renal artery stenosis
    T. A. Bouwmeester, D. Collard, I. A. J. Zijlstra +5
    medRxivPreprintCC BY-NC-NDFull textMedical imaging & radiologymedRxiv
  5. Determining core quality of life outcomes for patients with vulvar cancer and their partners: a Delphi consensus study.
    Astrid Machielsen, Nikki Meijer, Jessy van Dongen +8
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{liaw2026interaction,
  title = {{Interaction Between Age and the NOTCH3 p.R544C Variant in Determining Ischemic Stroke Risk: Insights from the Taiwan Biobank Study of 8,588 Patients.}},
  author = {Yi-Ching Liaw and Oswald Ndi Nfor and Che-Hong Chen and Shu-Yi Hsu and Yi-Chia Liaw and Yung-Po Liaw},
  journal = {International journal of medical sciences},
  year = {2026},
  month = sep,
  doi = {10.7150/ijms.132147},
  url = {https://europepmc.org/article/MED/42910061},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Interaction Between Age and the NOTCH3 p.R544C Variant in Determining Ischemic Stroke Risk: Insights from the Taiwan Biobank Study of 8,588 Patients.
AU  - Yi-Ching Liaw
AU  - Oswald Ndi Nfor
AU  - Che-Hong Chen
AU  - Shu-Yi Hsu
AU  - Yi-Chia Liaw
AU  - Yung-Po Liaw
PY  - 2026
DA  - 2026/09/24
JO  - International journal of medical sciences
DO  - 10.7150/ijms.132147
UR  - https://europepmc.org/article/MED/42910061
AB  - Genetic susceptibility to ischemic stroke may vary across the life course, yet the extent to which aging modifies the effect of specific high-risk variants remains incompletely understood. The NOTCH3 rs201118034 (p.R544C) variant, a CADASIL-related mutation with relatively high prevalence in East Asian populations, has been associated with cerebrovascular disease. We investigated whether age modifies the association between the NOTCH3 p.R544C variant and ischemic stroke risk at the population level. We integrated data from the Taiwan Biobank (TWB, 2008-2020) with the National Health Insurance Research Database (NHIRD, 2000-2020). Among 112,500 participants, 8,588 ischemic stroke cases were identified. Participants were classified as wild-type (GG) or p.R544C carriers (AG+AA). Logistic regression models were used to estimate stroke risk after adjusting for demographic characteristics, vascular comorbidities, and lifestyle factors. Effect modification by age was evaluated using interaction terms and age-genotype-stratified analyses. Overall, p.R544C carriers exhibited a higher prevalence of ischemic stroke than noncarriers (10.37% vs. 7.61%). The p.R544C variant was associated with higher odds of ischemic stroke (adjusted odds ratio [OR], 1.54; 95% confidence interval [CI], 1.24-1.90). Age was a strong determinant of stroke risk, and a significant interaction between age and genotype was observed (p for interaction = 0.02), indicating that the effect of age on ischemic stroke risk varied by genotype. In the joint age-genotype model, the highest odds of ischemic stroke were observed among AG+AA carriers aged 51-60 years (OR 7.07, 95% CI 5.08-9.82) and 61-70 years (OR 11.40, 95% CI 8.02-16.19), relative to 30-40-year-old GG carriers. These findings indicate that the association between the NOTCH3 p.R544C variant and ischemic stroke risk is age-dependent. The progressively stronger genetic effect observed in later adulthood underscores the importance of incorporating age-specific genetic susceptibility into population-based stroke risk stratification and neurogenetic epidemiology.
SN  - 1449-1907
ER  -